Changes in cytokine secretion induced by altered peptide ligands of myelin basic protein peptide 85-99

被引:0
|
作者
Ausubel, LJ
Krieger, JI
Hafler, DA
机构
[1] HARVARD UNIV,SCH MED,INST MED,BOSTON,MA 02115
[2] BRIGHAM & WOMENS HOSP,CTR NEUROL DIS,LAB MOL IMMUNOL,BOSTON,MA 02115
[3] AUTOIMMUNE INC,DEPT IMMUNOL,LEXINGTON,MA 02173
来源
JOURNAL OF IMMUNOLOGY | 1997年 / 159卷 / 05期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Myelin basic protein (MBP)-specific T cells were isolated directly from peripheral blood by stimulation either with native MBPp85-99 or altered peptide ligands (APLs) in which substitutions of the lysine were made at position 93, a TCR contact residue, We report here that the APL 93A could alter the cytokine profile of some autoreactive MBPp85-99 reactive T cell clones, switching them from a Th0 phenotype secreting high concentrations of IL-4, IL-5, and IFN-gamma into Th2 cells secreting significantly less IFN-gamma, However, in vitro stimulation with the 93A peptide, in some instances, induced T cells that responded better to the native MBPp85-99 peptide, Functionally, the APL 93A was shown to act as an antagonist for IFN-gamma secretion, Based on TCR sequencing and single cell cloning, this alteration in cytokine profile was determined to be the result of the differential activation of individual T cell clones, We discuss the implications of these data for the strength of signal model of T cell activation.
引用
收藏
页码:2502 / 2512
页数:11
相关论文
共 50 条
  • [1] Altered peptide ligands of myelin basic protein (MBP) peptide 85-99 induce IL-4 but not IFN-gamma cytokine secretion in human MBP specific T cells
    Ausubel, LJ
    Krieger, JI
    Hafler, DA
    NEUROLOGY, 1997, 48 (03) : 64002 - 64002
  • [2] Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99)
    Vergelli, M
    Hemmer, B
    Utz, U
    Vogt, A
    Kalbus, M
    Tranquill, L
    Conlon, P
    Ling, N
    Steinman, L
    McFarland, HF
    Martin, R
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (11) : 2624 - 2634
  • [3] Altered peptide ligands of myelin basic protein produce persistent antidepressant-like effects
    Sun, Cheng-Yu
    Xu, Ling-Zhi
    Meng, Shi-Qiu
    Deng, Jia-Hui
    Lu, Lin
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 88 - 89
  • [4] Altered peptide ligands of myelin basic protein (MBP87-99) conjugated to reduced mannan modulate immune responses in mice
    Katsara, Maria
    Yuriev, Elizabeth
    Ramsland, Paul A.
    Tselios, Theodore
    Deraos, George
    Lourbopoulos, Athanasios
    Grigoriadis, Nikolaos
    Matsoukas, John
    Apostolopoulos, Vasso
    IMMUNOLOGY, 2009, 128 (04) : 521 - 533
  • [5] Effects of altered peptide ligands on human myelin basic protein peptide (83-99) specific T cells: A basis for the design of specific immunotherapies in multiple sclerosis?
    Hemmer, B
    Vergelli, M
    Tranquill, L
    Conlon, P
    Ling, N
    McFarland, HF
    Martin, R
    NEUROLOGY, 1997, 48 (03) : 2065 - 2065
  • [6] Comparison of proposed putative bioactive conformations of altered peptide ligands of myelin basic protein by spectroscopic and modelling studies
    Mantzourani, F. D.
    Mavromoustakos, T. M.
    Golic-Grdadolnik, S.
    Platts, J. A.
    Deraos, G. N.
    Matsoukas, J. M.
    Tselios, T. V.
    JOURNAL OF PEPTIDE SCIENCE, 2006, 12 : 189 - 189
  • [7] Cross-reactivity of T-cell clones specific for altered peptide ligands of myelin basic protein
    Ausubel, LJ
    Bieganowska, KD
    Hafler, DA
    CELLULAR IMMUNOLOGY, 1999, 193 (01) : 99 - 107
  • [8] Design of novel cyclic altered peptide ligands of myelin basic protein MBP83-99 that modulate immune responses in SJL/J mice
    Katsara, Maria
    Deraos, George
    Tselios, Theodore
    Matsoukas, John
    Apostolopoulos, Vasso
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3971 - 3978
  • [9] Differential signaling and hierarchical response thresholds induced by an immunodominant peptide of myelin basic protein and an altered peptide ligand in human T cells
    Crowe, PD
    Boehme, SA
    Wong, T
    Gaur, A
    Sidney, J
    Sette, A
    Conlon, PJ
    HUMAN IMMUNOLOGY, 1998, 59 (11) : 679 - 689
  • [10] Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
    Bibiana Bielekova
    Bonnie Goodwin
    Nancy Richert
    Irene Cortese
    Takayuki Kondo
    Ghazaleh Afshar
    Bruno Gran
    Joan Eaton
    Jack Antel
    Joseph A. Frank
    Henry F. McFarland
    Roland Martin
    Nature Medicine, 2000, 6 : 1167 - 1175